Biofrontera Ratios (2020-2025) | BFRI

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
96.56%97.69%99.05%98.03%98.21%96.59%97.73%-72.27%47.33%52.60%49.47%112.80%47.98%44.61%45.88%58.03%61.95%70.74%70.74%82.40%
EBT Margin (Quarter)
-74.47%-61.78%-369.31%-158.16%57.34%-19.07%-59.35%-27.44%-85.57%-167.97%-71.28%33.22%-131.90%-3.02%-62.87%-11.14%-48.95%-58.73%-95.06%32.98%
EBIT Margin (Quarter)
-73.78%-62.97%-371.60%-20.74%-31.89%-139.38%-84.20%-55.02%-62.89%-148.75%-51.93%-36.48%-69.10%-64.69%-55.04%-13.63%-52.95%-56.25%-89.84%26.66%
EBITDA Margin (Quarter)
-73.78%-62.97%-371.60%-20.74%-31.89%-139.38%-84.20%-55.02%-62.89%-148.75%-51.93%-36.48%-69.10%-64.69%-55.04%-13.63%-52.95%-56.25%-89.84%26.66%
Operating Margin (Quarter)
-73.78%-62.97%-371.60%-20.74%-31.89%-139.38%-84.20%-55.02%-62.89%-148.75%-51.93%-36.48%-69.10%-64.69%-55.04%-13.63%-52.95%-56.25%-89.84%26.66%
Net Margin (Quarter)
-74.49%-62.53%-369.45%-158.21%57.03%-19.07%-59.37%-27.45%-85.63%-168.21%-71.29%33.28%-131.91%-3.28%-62.91%-11.12%-48.94%-58.96%-95.15%32.98%
FCF Margin (Quarter)
-72.58%-18.05%-28.24%-229.05%-21.71%2.11%-137.48%-81.56%-42.53%-176.56%-22.53%-83.64%-42.75%-60.12%-13.40%-7.78%-47.78%-34.34%-54.15%-14.12%
Efficiency
Inventory Average (Quarter)
4.95M4.67M6.84M10.45M9.63M6.92M13.49M8.91M5.43M5.24M6.59M6.59M5.28M4.18M2.88M
Assets Average (Quarter)
34.29M51.21M51.41M54.34M52.97M46.42M31.02M26.25M23.07M20.05M20.31M19.34M18.36M17.78M21.99M
Equity Average (Quarter)
4.06M0.46M-9.37M-3.02M14.38M17.32M19.91M23.24M20.31M11.96M4.11M2.92M-0.31M2.75M8.22M4.98M2.47M-2.08M-3.62M3.95M
Invested Capital (Quarter)
2.29M-1.37M-17.38M14.58M17.42M17.23M25.84M30.82M23.78M7.17M8.25M8.70M-3.06M11.21M5.53M4.43M0.50M-4.67M-2.58M10.48M
Asset Utilization Ratio (Quarter)
0.700.570.540.510.540.601.101.271.531.761.841.962.132.091.90
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-107.44-27.03-3.85-551.11-31.13-37.89
Debt to Equity (Quarter)
0.290.140.290.426.950.81-0.430.03
Debt Ratio (Quarter)
0.060.060.140.170.210.140.100.01
Equity Ratio (Quarter)
-1.130.210.350.320.410.470.400.030.17-0.220.510.300.200.03-0.23-0.170.37
Times Interest Earned (Quarter)
-107.44-27.03-3.85-551.11-31.13-37.89
Valuation
Enterprise Value (Quarter)
-1.70M-24.55M-22.40M-31.90M-27.52M-27.75M-8.90M-6.72M-1.42M-3.84M-4.39M-2.91M-5.91M-1.79M-7.21M-3.41M-6.41M
Return Ratios
Return on Sales (Quarter)
-0.01%-0.01%-0.04%-0.02%0.01%0.00%-0.01%0.00%-0.01%-0.02%-0.01%0.00%-0.01%0.00%-0.01%0.00%0.00%-0.01%-0.01%0.00%
Return on Capital Employed (Quarter)
-123.19%-63.84%-74.79%-39.95%-57.80%-80.56%-175.38%-185.40%-137.78%-214.83%-207.66%-194.26%1,232.83%-337.12%-112.39%
Return on Invested Capital (Quarter)
-0.21%0.03%0.18%-0.02%-0.02%-0.01%-0.01%-0.01%-0.02%-0.03%-0.03%-0.08%-0.05%-0.02%-0.03%-0.07%0.08%0.05%-0.03%
Return on Assets (Quarter)
-0.01%-0.01%-0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%
Return on Equity (Quarter)
-0.22%0.02%0.12%-0.02%-0.01%-0.01%0.00%-0.01%-0.02%-0.06%-0.07%0.74%-0.05%-0.02%-0.04%-0.05%0.08%0.05%-0.03%